Recent prospective studies have shown that several markers of systemic infl
ammation may be used to predict future cardiovascular events. High-sensitiv
ity testing for C-reactive protein has received most of the attention. We m
easured serum CRP in a total number of 312 patients on hemodialysis in comp
arison with 300 sex matched healthy controls. We found, that a considerable
number of hemodialysis patients exhibit an activated acute phase response
(8-fold higher CRP levels in hemodialysis patients than in controls), which
is closely related to high levels of atherogenic vascular risk factors and
cardiovascular death. The mechanisms of activated acute phase reaction in
patients on chronic hemodialysis remain to be identified, since a successfu
l treatment of the inflammatory condition may improve long-term survival in
these patients. Two major questions need to be clarified: 1) Should we sea
rch for a stimujlatory factor chat is dialysis dependent? or 2) Should we s
upport the hypothesis that a systemic factor, uremia related or altered by
uremia, is responsible for the high CRP levels in hemodialysis patients?